S Korea's SK Biopharmaceuticals shares soar 30% in market debut

Photo by Louis Reed on Unsplash

SK Biopharmaceuticals Co Ltd saw its share price jump nearly 30% in a Seoul stock market debut on Thursday, as the initial public offering (IPO) market gathers steam after the novel coronavirus outbreak stalled potential listings.

SK Biopharmaceuticals’ shares debSKuted at double their IPO price on Thursday at 98,000 won, valuing the company about 7.7 trillion won ($6.41 billion).

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter